28 Sep 2015 Ron Muhlenkamp: Rhetoric risk in biotech will continue ( Portfolio )
Ron Muhlenkamp, Muhlenkamp Fund founder and portfolio manager, provides perspective on where to invest and the current state of the U.S. economy.